Bracco Diagnostics Inc. announced the availability of its Isovue (iopamidol injection) Imaging Bulk Package (IBP), a specific combination multi-patient, multi-dose compliant contrast medium approved by the U.S. Food and Drug Administration (FDA) for point-of-care use in the computed tomography (CT) suite.

The accurate measurement of mammographic density offers the potential to improve breast cancer risk prediction and to tailor screening protocols according to risk, according to a study published in Breast Cancer Research (16:439 doi:10.1186/s13058-014-0439-1). The article, “Digital mammographic density and breast cancer risk: a case-control study of six alternative density assessment methods,” demonstrates a strong connection between breast density and breast cancer risk. 

RedRick Technologies, a provider of ergonomic radiology workstations, monitor mounting solutions and reading room environment guidance, has helped the new Penn Musculoskeletal Center implement their newest musculoskeletal radiology reading room, which may also serve as a model for future reading room designs at Penn Medicine.

Gamma Medica announced the company now offers Philips MicroDose SI, the first full-field digital mammography (FFDM) system that supports single-shot, non-invasive spectral imaging, as a complement to its market leading LumaGEM Molecular Breast Imaging (MBI) system. LumaGEM is a highly effective and cost-efficient technology for detecting breast cancer in patients with complex mammograms and dense breast tissue. The agreement with Philips will enable Gamma Medica to provide breast imaging suites with the option to purchase both technologies and offer the most advanced and safest commercially available dense breast solution for women. Philips will continue selling MicroDoseSI directly to customers.

Volpara Solutions will exhibit its complete suite of quantitative breast imaging tools built on the Volpara Solutions software engine that allows for personalized measurements of volumetric breast density, patient-specific dose, breast compression and other factors designed to maintain accuracy and consistent quality in breast screening.

Lung cancer patients with minimally invasive adenocarcinoma have similar, positive five-year disease-free survival (DFS) and overall survival (OS) rates as patients with adenocarcinoma in-situ.

Spellman High Voltage Electronics Corp. will present at RSNA 2014, high voltage solutions for the diagnostic medical imaging industry.

Novarad will display its latest advancements at the Radiological Society of North America’s (RSNA) 2014 conference, with anticipated products including: an improved MARZ Universal Viewer, a redesigned user interface and NovaGlass, a service that enables users to view images on any device.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now